Bacterial therapy is emerging for the treatment of cancers though some scientific and clinical problems have not been addressed. Here, a living drug-loaded carrier, paclitaxel-in-liposome-in-bacteria (LPB), was prepared for inhalation treatment of primary lung cancer, where liposomal paclitaxel (LP) was highly effectively internalized into bacteria (E. coli or L. casei) to get LP-in-E. coli (LPE) or LP-in-L. casei (LPL) by electroporation that had no influence on the growth of these bacteria. Bacteria, LP, the simple mixture of LP and bacteria, and LPB remarkably inhibit the proliferation of A549 lung cancer cells, where LPE is the strongest one. Drug-loaded bacteria can delivers the cargos into the cells more quickly than the mixture of drugs and bacteria and the cargos alone. LPE also shows the highest anticancer effect on the rat primary lung cancer among them with the downregulation of VEGF and HIF-1α and the improvement of cancer cell apoptosis. Moreover, the bacterial formulations significantly enhance the expressions of immune markers (TNF-α, IL-4, and IFN-γ) and immune cells (leukocytes and neutrophils). After inhalation to the rat lungs, LPB shows much higher bacterial distribution in the lung than other organs. LPB is a promising medicine for inhalation treatment of primary lung cancer.Copyright © 2020. Published by Elsevier B.V.
Shorter Time to Surgery Is Associated With Better Outcomes for Spondylolisthesis in the Workers’ Compensation Population.
March 20, 2020
Impact of Chronic Kidney Disease on Atrial Fibrillation Recurrence Following Radiofrequency and Cryoballoon Ablation: A Meta-Analysis.
March 25, 2021
September 17, 2020
July 6, 2013
- ASCO – Lung CancerASCO.20 Virtual Scientific Program, held May 29 - 31, brought professionals from all over the world together to hear the brightest minds in oncology present state-of-the-art treatment modalities and new therapies.
- AACR-2020The American Association for Cancer Research is the world's oldest and largest professional association related to cancer research.
- ACC 2020The American College of Cardiology decided to cancel ACC.20/WCC due to COVID-19, which was scheduled to take place March 28-30 in Chicago. However, ACC.20/WCC Virtual Meeting continues to release cutting edge science and practice changing updates for cardiovascular professionals on demand and free through June 2020.
- ASCO 2019The 2019 ASCO Annual Meeting, taking place May 31-June 4 in Chicago, will bring together more than 32,000 oncology professionals from across the globe. The theme of this year’s conference is Caring for Every Patient, Learning From Every Patient.